GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Shagore Tarn
Country: Singapore
Language: English (Spanish)
Genre: Medical
Published (Last): 27 March 2016
Pages: 176
PDF File Size: 20.36 Mb
ePub File Size: 18.71 Mb
ISBN: 728-6-97979-650-7
Downloads: 73933
Price: Free* [*Free Regsitration Required]
Uploader: Fejora

During the initial and final visits for the intervention group, the intervention was accepted and the health problem was solved in 72 cases A guidance statement from the American College of Physicians. On the other hand, hypertension and DM are the most important risk factors that lead to deterioration in renal function, because the kidney is one of the target organs in these conditions; at the same time, together they will increase the cardiovascular risk 22 In Barranquilla, the prevalence of CKD is of approximately 46 persons perinhabitants 1.

The prevalence and incidence of CKD which requires renal replacement therapy has increased progressively in Colombia; currently there are approximately 20, persons under renal replacement therapy, which represents a prevalence of patients per one million inhabitants.

Evaluation of risk factors for development of complications in Type II diabetes in Europe. Additionally, we sought to determine the costs of caring for these patients during the study period. NOM are classified into problems of necessity, effectiveness, and safety; necessity NOM include untreated health problems and the effects of unnecessary medications, effectiveness NOM include the quantified and non-quantified ineffectiveness, and safety NOM include quantified and non-quantified lack of safety 9 In the future, in case pharmacotherapeutic monitoring is incorporated to daily care of diabetic patients, commitment is needed from healthcare insurance carriers EPS to make available the offices for the interviews, facilitate easier access to clinical records and paraclinical exams, updates of member addresses, generation of settings for meetings and discussion with treating physicians to socialize the NOM findings and the pharmaceutical recommendations, implement recommendations, and evaluate results.

  ALGEBRA LINIOWA 2 SKOCZYLAS DEFINICJE PDF

Each of the patients had a replacement selected randomly and with the same characteristics.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

The high frequency of the necessity NOM As the incidence of type 2 diabetes escalates, gguia developments offer hope for better treatments, reports. Guide to drug dosage in renal failure. A study conducted in Spain in found that three out of every four patients admitted to emergengy services were because of an NOM 11 There will be an increasing number of persons with CKD who will need to undergo treatments with side effects at short, medium and long term 5.

Parametric and non-parametric hypotheses tests were run for related samples, comparing the initial and final glycated hemoglobin within the same groups.

Poor control of patients with type-2 diabetes mellitus is a problem affecting all nations. Pharmacotherapeutic records were the primary source of information and the secondary sources were the clinical histories, the status of the condition, records of medications dispensed by quantities and costs, along with the data base from the EPS services with the records of services rendered to their users, appointments with their treating physicians, authorizations for paraclinical exams requested by the physicians, among others.

Therefore, it is necessary to involve all healthcare professionals and patients, in order to obtain as a result a better use of medications, to prevent NOMs, and to reduce the morbidity associated with drug therapy. The highest prescription was for Group C, Cardiovascular System, with medications; this means that patients with CKD are administered a higher number of medications acting upon this diabetew system.

Pharmacotherapeutic Monitoring Farmacoterxpeutico is defined as the professional practice in which the pharmacist assumes responsibility for the needs of the patient related to medications. Statistical Analysis The outcomes of the pharmaceutical interventions segui,iento the study were statistically analyzed with the STATA program version Besides, in our study, there were more reports for Quantitative Ineffectiveness; the reason for this was the lack of modification in treatment dosing, even when this was allowed by the therapeutic window of drugs.

  BRONOWSKI ASCENT MAN PDF

La HbA1c inicial tuvo un promedio de 7. Cost of diabetes mellitus in Spain. The loss seguimidnto The present study was conducted in order to understand the types of drug-related problems, and the negative outcomes associated with medications, that can be detected, prevented and solved in patients with chronic kidney disease, through pharmaceutical care practice.

Direct health care costs of diabetic patients in Spain. One of the options to prevent NOMs is through education, which was a key factor for developing this study, because it generated higher trust among health professionals, patients, and the Pharmacist.

Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

The main reasons for this are:. The intervention was accepted but the health problem was not solved in 21 cases The authors manifest and declare having no conflict of interest. Solution of negative outcomes associated with medication. It is worth mentioning that in the study carried out, there was an important loss of patients A descriptive analysis was conducted with central tendency and dispersion measures for quantitative variables, and relative frequencies for qualitative variables.

Results In total, 47 patients accepted to enter the PCP program; 21 of them were men and 26 were women. Patients in the control group were subjected to HbA1c measurement at the beginning and end of the study; they also had an initial interview with the pharmacotherapeutical record format, according to the DADER methodology.

Opportunities and responsabilities in the Pharmaceutical Care.

Effectiveness the pharmaceutical care in diabetic patients* | Machado -Alba | Colombia Médica

Patients were handed an Informed Consent for accepting or not. Declaration of conflict of interest. Rev Asoc Latinoam Diabetes. These findings suggest that the active involvement of Pharmacists in the treatment of renal anaemia for patients under hemodialysis had a great therapeutic impact.